|
Date
|
Description
|
News
|
|
07/14/2010
|
Press Release: "Reduce Infection Risks - Potential Savings from Using
Intelligent Medical Technology"
At the medical technology Clustermeeting “Anti-Infective Protection for
Implants” at Heraeus Medical in Wehrheim scientific and industrial experts
were recently briefed on potential cost-savings in healthcare and on current
innovations in the field of medical implants.
Press Release: Reduce Infection Risks"
|
Information AntibiotiCoat® coating technology for medical implants
|
|
02/01/2010
|
The name of the Heraeus‘ primary bone cement is changing from PALAMED® to PALACOS® MV (medium viscosity).
The name change will be done to increase product transparency for our customers. In the future all bone cements for primary arthroplasty will be known by the name PALACOS®, followed by a suffix indicating the viscosity. All cements are based on the same proven ingredients and are available with the addition of Gentamicin as well.
(Exceptions: In Spain, Greece, Italy and Poland the product name will remain unchanged).
|
Flyer
|
|
09/04/2009
|
50 years of PALACOS® R – the gold standard among bone cements
In 1958 British Orthopaedic Surgeon Sir John Charnley Implanted a hip endoprosthesis with PMMA cement for the first time ever.
|
News
|
|
|
|
|
|
06/25/2009
|
Expansion of the product range
PALACOS®LV and LV+G now also available in 1x20
The low-viscosity bone cements PALACOS®LV and PALACOS® LV+G are now available in the 1 x 20 package size.
|
News
|
|
|
|
|
|
05/28/2009
|
COPAL® - The new product line for revision arthroplasty
Heraeus is expanding its product portfolio and establishing a new product line for revision arthroplasty.
|
News
|
|
|
|
|
